Relay Therapeutics, Inc. — Director's Dealing 2023

Jun 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Relay Therapeutics, Inc. (RLAY)
CIK: 0001812364
Period of Report: 2023-05-31

Reporting Person: Rubin Jami (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-31	Stock Option (Right to Buy)	$11.14	A	66055	Acquired	2033-05-30	Common Stock (66055)	Direct

Footnotes

F1: This option was granted on May 31, 2023 with respect to 66,055 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.